Shop

Fluorecare COMBO 9in1 test | SARS-CoV-2 | Influenza A+B | RSV | Adenovirus | hMPV | Rhinovirus | PIV | Mycoplasma Pneumoniae

59,99 PLN per piece

Work efficiently, order profitably!
Place wholesale orders at info@bisaf.pl

Intended for professional use.

In stock

 zł

Product description

Fluorecare COMBO 9in1 test (nasal swab/nasopharyngeal swab/throat swab)

 

This is a rapid test designed for the qualitative and differential detection of antigens for SARS-CoV-2, Influenza A and B, RSV, Adenovirus, Human Metapneumovirus (hMPV), Rhinovirus, Parainfluenza Virus (PIV), and Mycoplasma pneumoniae. The sample can be collected from the patient’s nose, nasopharynx, or throat.

1 swab = 9 results

The high sensitivity and specificity of this test ensure reliable and accurate results, available in just 12 minutes!

For professional use only.

Properties

  • sample material: nasal swab, nasopharyngeal swab or throat swab
  • painless sample collection
  • high-quality product
  • rapid results in just 12 minutes
  • single packaging
  • intended for professional use

Test specification

  • SARS-CoV-2: specificity: 100%, sensitivity: 92.93%, accuracy: 96.11%
  • Influenza A: specificity: 96.88%, sensitivity: 95.71%, accuracy: 96.27%
  • Influenza B: specificity: 96.88%, sensitivity: 92.86%, accuracy: 94.78%
  • RSV: specificity: 100%, sensitivity: 98.72%, accuracy: 99.44%
  • Adenovirus: specificity: 100%, sensitivity: 98.06%, accuracy: 99.03%
  • hMPV: specificity: 100%, sensitivity: 98.04%, accuracy: 99.05%
  • Rhinovirus: specificity: 98.68%, sensitivity: 97.48%, accuracy: 98.06%
  • PIV: specificity: 98.75%, sensitivity: 98.08%, accuracy: 98.42%
  • Mycoplasma pneumoniae: specificity: 96.36%, sensitivity: 97.01%, accuracy: 96.72%

The package contains

  • 1 test cassette
  • 1 single-use sterile swab
  • 1 extraction buffer
  • user manual

Test application

  • This test is designed for the qualitative assessment of infections caused by SARS-CoV-2, Influenza A, Influenza B, RSV, Adenovirus, Human Metapneumovirus (hMPV), Rhinovirus, Parainfluenza Virus (PIV), and Mycoplasma pneumoniae. It enables the rapid detection or exclusion of the cause of a patient’s symptoms.
  • The test is particularly recommended for pediatricians, as children are exposed to such infections in school and preschool environments. Painless sample collection makes it suitable for the youngest patients.
  • It is also intended for screening in primary care facilities and general practitioners’ offices, allowing for the rapid confirmation or exclusion of infection with one of the six most common respiratory pathogens.